A phase II study of continuous infusion 5‐fluorouracil in advanced hormone refractory prostate cancer. An illinois cancer center study
Timothy M. Kuzel*, Martin S. Tallman, Daniel Shevrin, Edward Braud, Lary Kilton, Patricia Johnson, James Kozlowski, Nicholas J. Vogelzang, Richard Blough, Al B. Benson
Dive into the research topics of 'A phase II study of continuous infusion 5‐fluorouracil in advanced hormone refractory prostate cancer. An illinois cancer center study'. Together they form a unique fingerprint.